Language: English
This service contains links to third party websites. EPG Patient Direct is not in a position to verify this information and cannot be held responsible for the accuracy of the content contained.
28 Aug 2008
Early medication use could slow down the progression of Parkinson's disease, according to new research.
The international study, which involved more than 1,000 patients from Europe, the UK and USA, showed people who took the drug rasagiline soon after being diagnosed with the condition had a less aggressive form of the condition than those who did not take it until later on.
Parkinson's is a progressive neurological condition which affects movements like talking, walking and writing.
It was found that people who took the medication were in better shape after 18 months than those who delayed treatment by nine months.
Presenting their findings at the European Federation of Neurological Societies Congress, the doctors who carried out the study said they believe the drug works by creating a long-lasting protection for brain cells.
However, the researchers stressed that much more work is required to establish the long-term impact of the medication.
More health news
Delicious
Reddit
Facebook
StumbleUpon
